Last reviewed · How we verify
Oxytocin IV
At a glance
| Generic name | Oxytocin IV |
|---|---|
| Also known as | Pitocin |
| Sponsor | Sheba Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage (PHASE4)
- Efficacy of Intravenous Oxytocin to Speed Recovery After THA (PHASE2)
- Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography (PHASE2)
- Cooling the Uterus in C-section After Dysfunctional Labor (NA)
- Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain (PHASE2)
- Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor (PHASE4)
- Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter (NA)
- The Role of Oxytocin in the Second Stage of Labor (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |